These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 18811684)

  • 1. Mechanism of tyrosinase inhibition by deoxyArbutin and its second-generation derivatives.
    Chawla S; deLong MA; Visscher MO; Wickett RR; Manga P; Boissy RE
    Br J Dermatol; 2008 Dec; 159(6):1267-74. PubMed ID: 18811684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DeoxyArbutin and its derivatives inhibit tyrosinase activity and melanin synthesis without inducing reactive oxygen species or apoptosis.
    Chawla S; Kvalnes K; deLong MA; Wickett R; Manga P; Boissy RE
    J Drugs Dermatol; 2012 Oct; 11(10):e28-34. PubMed ID: 23134995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy and safety of deoxyarbutin, a new tyrosinase-inhibiting agent.
    Hamed SH; Sriwiriyanont P; deLong MA; Visscher MO; Wickett RR; Boissy RE
    J Cosmet Sci; 2006; 57(4):291-308. PubMed ID: 16957809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency.
    Boissy RE; Visscher M; DeLong MA
    Exp Dermatol; 2005 Aug; 14(8):601-8. PubMed ID: 16026582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arbutin: mechanism of its depigmenting action in human melanocyte culture.
    Maeda K; Fukuda M
    J Pharmacol Exp Ther; 1996 Feb; 276(2):765-9. PubMed ID: 8632348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of the water-soluble polymer-wrapped derivative of fullerene on UVA-induced melanogenesis via downregulation of tyrosinase expression in human melanocytes and skin tissues.
    Xiao L; Matsubayashi K; Miwa N
    Arch Dermatol Res; 2007 Aug; 299(5-6):245-57. PubMed ID: 17333222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hydroquinone and its glucoside derivatives on melanogenesis and antioxidation: Biosafety as skin whitening agents.
    Hu ZM; Zhou Q; Lei TC; Ding SF; Xu SZ
    J Dermatol Sci; 2009 Sep; 55(3):179-84. PubMed ID: 19574027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of arbutin on melanin biosynthesis of alpha-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues.
    Lim YJ; Lee EH; Kang TH; Ha SK; Oh MS; Kim SM; Yoon TJ; Kang C; Park JH; Kim SY
    Arch Pharm Res; 2009 Mar; 32(3):367-73. PubMed ID: 19387580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
    Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of benzylidenebenzofuran-3(2H)-one (aurones) as inhibitors of tyrosinase derived from human melanocytes.
    Okombi S; Rival D; Bonnet S; Mariotte AM; Perrier E; Boumendjel A
    J Med Chem; 2006 Jan; 49(1):329-33. PubMed ID: 16392817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-(2,4-Dihydroxyphenyl)-3-(2,4-dimethoxy-3-methylpheny)propane inhibits melanin synthesis by dual mechanisms.
    Niki Y; Yoshida M; Ando H; Wakamatsu K; Ito S; Harada N; Matsui MS; Yarosh DB; Ichihashi M
    J Dermatol Sci; 2011 Aug; 63(2):115-21. PubMed ID: 21680155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey and mechanism of skin depigmenting and lightening agents.
    Parvez S; Kang M; Chung HS; Cho C; Hong MC; Shin MK; Bae H
    Phytother Res; 2006 Nov; 20(11):921-34. PubMed ID: 16841367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosinase modulation by five Rwandese herbal medicines traditionally used for skin treatment.
    Kamagaju L; Morandini R; Bizuru E; Nyetera P; Nduwayezu JB; Stévigny C; Ghanem G; Duez P
    J Ethnopharmacol; 2013 Apr; 146(3):824-34. PubMed ID: 23439030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural criteria for depigmenting mechanism of arbutin.
    Hori I; Nihei K; Kubo I
    Phytother Res; 2004 Jun; 18(6):475-9. PubMed ID: 15287073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying melanogenesis inhibitors from Cinnamomum subavenium with in vitro and in vivo screening systems by targeting the human tyrosinase.
    Wang HM; Chen CY; Wen ZH
    Exp Dermatol; 2011 Mar; 20(3):242-8. PubMed ID: 21054558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity.
    Gili A; Thomas PD; Ota M; Jimbow K
    Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent low toxicity inhibition of human melanogenesis by novel indole-containing octapeptides.
    Ubeid AA; Do S; Nye C; Hantash BM
    Biochim Biophys Acta; 2012 Oct; 1820(10):1481-9. PubMed ID: 22609875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of aloesin and arbutin on cultured melanocytes in a synergetic method].
    Yang ZQ; Wang ZH; Tu JB; Li P; Hu XY
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2004 Sep; 20(5):369-71. PubMed ID: 15623110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-sequence oligopeptides with inhibitory activity against mushroom and human tyrosinase.
    Abu Ubeid A; Zhao L; Wang Y; Hantash BM
    J Invest Dermatol; 2009 Sep; 129(9):2242-9. PubMed ID: 19440221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tyrosinase activity by 4-tert-butylcatechol and other depigmenting agents.
    Usami Y; Landau AB; Fukuyama K; Gellin GA
    J Toxicol Environ Health; 1980 May; 6(3):559-67. PubMed ID: 6775084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.